Kenneth P. Micklethwaite

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.

Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.

Journal: Blood
Published: January 12, 2026

Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction using three independent cohorts.

Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction using three independent cohorts.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 27, 2025

Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction Using Three Independent Cohorts.

Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction Using Three Independent Cohorts.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 27, 2025

Human herpesvirus 6 viremia and encephalitis in CAR T-cell recipients.

Human herpesvirus 6 viremia and encephalitis in CAR T-cell recipients.

Journal: Blood
Published: April 04, 2025

Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia.

Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia.

Journal: Frontiers in oncology
Published: November 28, 2024

Current developments in T-cell receptor therapy for acute myeloid leukemia.

Current developments in T-cell receptor therapy for acute myeloid leukemia.

Journal: Blood advances
Published: October 01, 2024

Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article.

Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article.

Journal: Human gene therapy
Published: July 25, 2024

Identification of clonally expanded γδ T-cell populations during CAR-T cell therapy.

Identification of clonally expanded γδ T-cell populations during CAR-T cell therapy.

Journal: Immunology and cell biology
Published: April 30, 2024

A new way of identifying viral pathogens reactivating in cellular therapy products.

A new way of identifying viral pathogens reactivating in cellular therapy products.

Journal: Immunology and cell biology
Published: January 19, 2024

CAR+ and CAR- T cells share a differentiation trajectory into an NK-like subset after CD19 CAR T cell infusion in patients with B cell malignancies.

CAR+ and CAR- T cells share a differentiation trajectory into an NK-like subset after CD19 CAR T cell infusion in patients with B cell malignancies.

Journal: Nature communications
Published: September 26, 2023

Chimeric antigen receptor T-cell therapy: Prospective observational study of unplanned emergency department presentations.

Chimeric antigen receptor T-cell therapy: Prospective observational study of unplanned emergency department presentations.

Journal: Emergency medicine Australasia : EMA
Published: January 16, 2023

Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis.

Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis.

Journal: Internal medicine journal
Published: December 23, 2022
Showing 1-12 of 45

Last Updated: 09/26/2026